Literature DB >> 23465746

[Retro-odontoid pseudotumor in diffuse idiopathic skeletal hyperostosis].

Julián Castro-Castro1, Daniel Castro-Bouzas2, Alfonso Pinzón-Millán2, Ana Pastor-Zapata2.   

Abstract

Retro-odontoid pseudotumors are lesions caused by inflammatory granulation or reactive soft tissue hypertrophy from chronic atlantoaxial subluxation. However, one-third of the cases reported in the medical literature did not show atlantoaxial instability clearly. The authors present the case of a 76-year-old man previously diagnosed with diffuse idiopathic skeletal hyperostosis who presented with severe progressive myelopathy. A magnetic resonance imaging of his cervical spine revealed a retro-odontoid predural mass, which caused a severe compression of the cervical spinal cord. The patient underwent a posterior laminectomy of the atlas and an occipitocervical fusion. After surgery, the pseudotumor was considerably smaller and the neurological symptoms improved.
Copyright © 2012 Sociedad Española de Neurocirugía. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Diffuse idiopathic skeletal hyperostosis; Fijación occipitocervical; Hiperostosis esquelética idiopática difusa; Mielopatía; Myelopathy; Occipito-cervical fusion; Pseudotumor retroodontoideo; Retro-odontoid pseudotumor

Mesh:

Year:  2013        PMID: 23465746     DOI: 10.1016/j.neucir.2013.01.001

Source DB:  PubMed          Journal:  Neurocirugia (Astur)        ISSN: 1130-1473            Impact factor:   0.553


  2 in total

Review 1.  Extraskeletal symptoms and comorbidities of diffuse idiopathic skeletal hyperostosis.

Authors:  Rabia Terzi
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

2.  Exploration for reliable radiographic assessment method for hinge-like hypermobility at atlanto-occipital joint.

Authors:  Shinjiro Kaneko; Ken Ishii; Kota Watanabe; Takashi Tsuji; Masaya Nakamura; Morio Matsumoto; Yoshiyuki Yato; Takashi Asazuma
Journal:  Eur Spine J       Date:  2017-10-20       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.